Remove 2024 Remove Cardiovascular Imaging Remove Plaque
article thumbnail

HeartFlow's Plaque Analysis Leading The Way: 95% Accuracy vs Invasive Imaging In Newly Published REVEALPLAQUE Study

DAIC

milla1cf Thu, 05/23/2024 - 08:00 May 23, 2024 — HeartFlow, Inc. , a leader in non-invasive artificial intelligence (AI) heart care solutions, announced that the data from its REVEALPLAQUE study , highlighting the accuracy of its Plaque Analysis, was published in the European Heart Journal Cardiovascular Imaging.

Plaque 52
article thumbnail

Artificial Intelligence Helps Coronary CT Angiography and Accelerates the Development of Precision Medicine

DAIC

©Science China Press milla1cf Wed, 01/17/2024 - 16:04 January 17, 2024 — This review was jointly published by Prof. Long-Jiang Zhang (Department of Radiology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University) and Prof.

article thumbnail

Results of CERTAIN Study Demonstrate Prominent Effects of Cleerly Products on Changing Clinical Management for Patients Suspected of Coronary Artery Disease

DAIC

25, 2024 in the European Heart Journal Cardiovascular Imaging. 25, 2024 in the European Heart Journal Cardiovascular Imaging 1. 25, 2024 in the European Heart Journal Cardiovascular Imaging 1. In Press European Heart Journal CV Imag 2024.This James Min, M.D.

article thumbnail

Predictors of Rapid Coronary Plaque Progression Measured by CT: More Opportunities to Optimize Prevention

Circulation: Cardiovascular Imaging

Circulation: Cardiovascular Imaging, Volume 17, Issue 7 , Page e017135, July 1, 2024.

Plaque 40
article thumbnail

Defining the Role of Lp(a) in High-Risk Plaques: The Road to Validation of IVUS, NIRS, OCT, and CTA Approaches

Circulation: Cardiovascular Imaging

Circulation: Cardiovascular Imaging, Volume 17, Issue 11 , Page e017613, November 1, 2024.

article thumbnail

Cleerly ISCHEMIA Software Device Billable With AMA Category I CPT Code for Noninvasive Estimates of Fractional Flow Reserve

DAIC

milla1cf Fri, 02/23/2024 - 11:54 February 23, 2024 — Cleerly , the company creating a new standard of care to aid in the diagnosis of heart disease, announced that its recently U.S. in European Association of Cardiovascular Imaging: Late Breaking Clinical Research and Trials. Barcelona, Spain.

Ischemia 105
article thumbnail

Cleerly Raises $106 Million in Series C Extension Funding

DAIC

tim.hodson Thu, 12/05/2024 - 11:59 Dec. 4, 2024 – Cleerly has successfully closed its latest Series C extension funding round, raising a total of $106 million. Cleerly’s pioneering approach to advanced cardiovascular imaging, powered by AI-driven analysis, is elevating the field of diagnostic tools for coronary artery disease.